ArticleBMC complementary medicine and therapies2025
Mechanism of Salvia miltiorrhiza in the treatment of periodontitis: integrative analyses via network pharmacology, molecular dynamics, and cellular assays.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vestitol Ameliorates Ferroptosis-Associated Features and Osteoarthritis Progression Through Modulation of the GSK3B/Nrf2/GPX4 Pathway.Cell biochemistry and biophysics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPeriodontitis is the primary cause of tooth loss in adults and is associated with cardiovascular disorders and type 2 diabetes, etc., significantly impairing patients' quality of life. Salvia miltiorrhiza(S. miltiorrhiza), a traditional Chinese medicine, possesses properties such as anti-inflammatory and antioxidative effects and has potential in the treatment of periodontitis; however, its mechanism of action remains unclear. The aim of this study was to investigate the therapeutic mechanism of S. miltiorrhiza in periodontitis using an integrated approach combining network pharmacology, molecular docking, molecular dynamics simulations, and experimental validation.
methodsThe active components and target genes of Salvia miltiorrhiza were collected from the TCMSP and SwissTargetPrediction databases, while the target genes of periodontitis were obtained from the GeneCards, OMIM, Disgenet, and DrugBank databases. The intersection of these targets was identified using jvenn, followed by network visualization using STRING and Cytoscape 3.10.2 software. CytoNCA plug-ins were used to calculate node scores and identify hub genes. The DAVID database was used to conduct Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Molecular docking and molecular dynamics simulation were employed to evaluate the affinity and stability between key active compounds of S.miltiorrhiza and the hub genes. A RAW264.7 cell model induced by Pg-LPS (Porphyromonas gingivalis-lipopolysaccharide) was established. A CCK-8 assay was used to determine the effects of S.miltiorrhiza on the viability of RAW264.7 cells, thereby screening for appropriate drug concentrations. The Griess method was used to test the effect of S. miltiorrhiza on nitric oxide (NO) in cells. The mRNA expression levels of inflammation-related factors were detected by RT-qPCR.
resultsA total of 65 compounds from S. miltiorrhiza and 132 corresponding target genes were identified, along with 1900 periodontitis-related target genes. The intersection of these targets revealed 60 common targets. PPI network analysis revealed that S. miltiorrhiza may alleviate periodontitis by modulating key genes, including IL-6, BCL2, STAT3, TNF, TP53, CASP3, and MMP9. Molecular docking indicated strong binding affinities between the bioactive compounds in S. miltiorrhiza and these critical targets. Functional enrichment analysis suggested that the anti-inflammatory action of S. miltiorrhiza in periodontitis may involve the regulation of pathways such as AGE-RAGE, TNF and PI3k/AKT1 pathways. The results of cell experiments revealed that S. miltiorrhiza could treat and prevent periodontitis by inhibiting NO production and regulating the mRNA expression of inflammatory factors, including IL-1β, TNF, IL-6, and IL-10.
conclusionS. miltiorrhiza exerts therapeutic effects on periodontitis via multiple components, targets and pathways, which provides a sufficient theoretical and practical basis for the further study of S. miltiorrhiza in the treatment of periodontitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.